Your account is not claimed yet. You can sign up with ORCID to claim your account.

Oliver Perra

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Preterm Infants

Virtual Reality

Top Venues

Pilot and feasibility studies

Developmental medicine and child neurology

Aging & mental health

Queen's University Belfast

University of Sheffield (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen's University Belfast May 1o 2013

United Kingdom

Lecturer :: School of Nursing & Midwifery

Education History

University of Sheffield Nov 1o 2000 - Jul 15o 2005

United Kingdom

PHD :: Psychology

Publications

Zeyun Feng, Thijs van den Broek, Oliver Perra, Jane Murray Cramm, Anna Petra Nieboer
Longitudinal health behaviour patterns among adults aged ≥50 years in China and their associations with trajectories of depressive symptoms. Aging & mental health (2022)
Oliver Perra, Fiona Alderdice, David Sweet, Alison McNulty, Matthew Johnston, Delfina Bilello, Kostas Papageorgiou, Sam Wass
Attention and social communication skills of very preterm infants after training attention control: Bayesian analyses of a feasibility study. PloS one 17 (9) (2022)
Oliver Perra, Sam Wass, Alison McNulty, David Sweet, Kostas A Papageorgiou, Matthew Johnston, Delfina Bilello, Aaron Patterson, Fiona Alderdice
Very preterm infants engage in an intervention to train their control of attention: results from the feasibility study of the Attention Control Training (ACT) randomised trial. Pilot and feasibility studies 7 (1) (2021)
Oliver Perra, Sam Wass, Alison McNulty, David Sweet, Kostas Papageorgiou, Matthew Johnston, Aaron Patterson, Delfina Bilello, Fiona Alderdice
Training attention control of very preterm infants: protocol for a feasibility study of the Attention Control Training (ACT). Pilot and feasibility studies 6 (2020)
Bethan Carter, C Verity Bennett, Hywel M Jones, Jackie Bethel, Oliver Perra, Ting Wang, Alison Mary Kemp
Healthcare use by children and young adults with cerebral palsy. Developmental medicine and child neurology 63 (1) (2020)